Hélène Labussière

1.0k total citations
44 papers, 451 citations indexed

About

Hélène Labussière is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Hélène Labussière has authored 44 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 14 papers in Genetics and 12 papers in Oncology. Recurrent topics in Hélène Labussière's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Hélène Labussière is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Hélène Labussière collaborates with scholars based in France, Belize and Spain. Hélène Labussière's co-authors include Franck E. Nicolini, Delphine Réa, Phillipp D. Le Coutre, Luciano Levato, Ivo Buschmann, Mauricette Michallet, Hervé Dombret, Francis J. Giles, Wilhelm Haverkamp and Bernd Dörken and has published in prestigious journals such as Blood, Cancer and Leukemia.

In The Last Decade

Hélène Labussière

42 papers receiving 444 citations

Peers

Countries citing papers authored by Hélène Labussière

Since Specialization

Citations

This map shows the geographic impact of Hélène Labussière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Labussière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Labussière more than expected).

Fields of papers citing papers by Hélène Labussière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Labussière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Labussière. The network helps show where Hélène Labussière may publish in the future.

Co-authorship network of co-authors of Hélène Labussière

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Labussière. A scholar is included among the top collaborators of Hélène Labussière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Labussière. Hélène Labussière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis 2025 ·Cancer Immunology Immunotherapy ·(unknown), Emmanuel Curis, Marie‐Hélène Schlageter, Nelly Bosselut, A Charbonnier, Marie‐Thérèse Rubio, Pascal Turlure, Hélène Labussière, Jacques‐Olivier Bay, Jérôme Cornillon, Laure Vincent, Corentin Orvain, Jean‐Jacques Kiladjian, David Michonneau, Gèrard Socié, Marie Robin	0
2	Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial 2024 ·Blood Cancer Journal ·Éolia Brissot, Myriam Labopin, Hélène Labussière, Gaëlle Fossard, Patrice Chevallier, Thierry Guillaume, Ibrahim Yakoub‐Agha, Micha Srour, Claude‐Eric Bulabois, Anne Huynh, Sylvain Chantepie, Anne‐Lise Ménard, Marie‐Thérèse Rubio, Patrice Céballos, Rémy Duléry, Sabine Fürst, Florent Malard, Didier Blaise, Mohamad Mohty	12
3	Sickle cell disease and acute leukemia: one case report and an extensive review 2023 ·Annals of Hematology ·Giovanna Cannas, Solène Poutrel, Maël Heiblig, Hélène Labussière, (unknown), Xavier Thomas, A. Hot	7
4	LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY 2020 ·Mediterranean Journal of Hematology and Infectious Diseases ·Xavier Thomas, (unknown), (unknown), (unknown), Gaëlle Fossard, Mohamed Elhamri, Alexandre Deloire, Marie Balsat, Fiorenza Barraco, Hélène Labussière, Sophie Ducastelle, (unknown), Eric Wattel, Maël Heiblig, Gilles Salles	2
5	Successful and Safe Treatment of Intestinal Graft-Versus-Host Disease (GvHD) with Pooled-Donor Full Ecosystem Microbiota Biotherapeutic: Results from a 29 Patient-Cohort of a Compassionate Use/Expanded Access Treatment Program 2020 ·Blood ·Florent Malard, Michaël Loschi, Faézeh Legrand, Raynier Devillier, (unknown), Cécile Borel, (unknown), Jérôme Cornillon, Amandine Le Bourgeois, Jean-Baptiste Méar, (unknown), Hélène Labussière, (unknown), Claude‐Eric Bulabois, (unknown), Mohamad Mohty	4
6	Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease 2018 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), (unknown), Mohamed Elhamri, Maël Heiblig, Alexandre Deloire, Sophie Ducastelle, Hélène Labussière, Fiorenza Barraco, Eric Wattel, Gilles Salles, Étienne Paubelle, Xavier Thomas	4
7	Skin allograft for severe chronic GvHD 2017 ·Bone Marrow Transplantation ·Roberto Crocchiolo, Valérie Dubois, (unknown), Mohamed Sobh, Sophie Ducastelle-Leprêtre, Hélène Labussière, Laure Lebras, Céline Auxenfans, Ali Mojallal, O. Damour, F. Braye, Mauricette Michallet	3
8	Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience 2016 ·Leukemia & lymphoma ·Maël Heiblig, (unknown), Mohamed Elhamri, Marie Balsat, Isabelle Tigaud, Adriana Pleșa, Fiorenza Barraco, Hélène Labussière, Sophie Ducastelle, Franck E. Nicolini, Eric Wattel, Gilles Salles, (unknown)	10
9	Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method 2016 ·Human Immunology ·Valérie Dubois, Marie Y. Detrait, (unknown), Stéphane Morisset, Hélène Labussière, (unknown), Franck E. Nicolini, (unknown), Valérie Mialou, Sophie Ducastelle, Sylvie Rey, Xavier Thomas, Fiorenza Barraco, (unknown), Évelyne Marry, Federico Garnier, Yves Bertrand, Mauricette Michallet	7
10	Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention 2015 ·Anaerobe ·Nagham Khanafer, Antoine Neuraz, Thomas Bénet, Martin Cour, Florence Persat, Hélène Labussière, (unknown), M. Michallet, Philippe Vanhems	2
11	Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings 2014 ·Leukemia & lymphoma ·Mauricette Michallet, Mohamad Sobh, (unknown), Stéphane Morisset, Hélène Labussière, Sophie Ducastelle, Fiorenza Barraco, Lila Gilis, Xavier Thomas, Franck E. Nicolini	5
12	Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib 2013 ·Leukemia ·(unknown), Delphine Réa, Michaela Schwarz, (unknown), Franck E. Nicolini, Gianantonio Rosti, Luciano Levato, Francis J. Giles, Hervé Dombret, Tristan Mirault, Hélène Labussière, Ruhdja Lindhorst, Wilhelm Haverkamp, Ivo Buschmann, Bernd Dörken, Phillipp D. Le Coutre	171
13	Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients 2013 ·Experimental Hematology ·Mauricette Michallet, Mohamad Sobh, Jean El Cheikh, Stéphane Morisset, Anne Sîrvent, Oumédaly Reman, Jérôme Cornillon, Reza Tabrizi, Nöel Milpied, Jean‐Luc Harousseau, Hélène Labussière, Franck‐Emmanuel Nicolini, Michel Attal, Philippe Moreau, Mohamad Mohty, Didier Blaise, Hervé Avet‐Loiseau	15
14	Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens 2012 ·Experimental Hematology ·Marie Y. Detrait, Valérie Dubois, Mohamad Sobh, Stéphane Morisset, (unknown), Hélène Labussière, (unknown), Fiorenza Barraco, Giovanna Cannas, Sophie Ducastelle, (unknown), Xavier Thomas, (unknown), Franck‐Emmanuel Nicolini, Mauricette Michallet	21
15	Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients 2012 ·Cancer ·Mauricette Michallet, (unknown), Mohamad Sobh, Stéphane Morisset, Youcef Chelghoum, Xavier Thomas, Fiorenza Barraco, Sophie Ducastelle, Hélène Labussière, (unknown), (unknown), C. Pivot, (unknown), Angélique Denis, (unknown), Marie Y. Detrait, Franck‐Emmanuel Nicolini, (unknown)	13
16	Appréciation quantitative du risque fongique en cas de travaux en établissements de santé : propositions d’indicateurs d’impact des mesures de gestion du risque infectieux fongique 2012 ·Journal de Mycologie Médicale ·Jean‐Pierre Gangneux, (unknown), Bernard Le Bonniec, Françoise Botterel, (unknown), O. Castel, Francis Derouin, Gautier Hoarau, Hélène Labussière, Matthieu Lafaurie, Laurence Millon, (unknown), Anne C. M. Thiébaut, M. Turco, (unknown)	14
17	Leukocytosis and Circulating Blasts in Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Are They Valuable Factors for Therapeutic Decision-Making? 2011 ·Clinical Lymphoma Myeloma & Leukemia ·Xavier Thomas, Youcef Chelghoum, Giovanna Cannas, Mohamed Elhamri, Hélène Labussière, Isabelle Tigaud, Sophie Ducastelle, Franck E. Nicolini, Charles Dumontet, Mauricette Michallet	7
18	Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience 2011 ·Haematologica ·Sophie de Guibert, Régis Peffault de Latour, Nathalie Varoqueaux, Hélène Labussière, Bernard Rio, (unknown), Jean‐Richard Eveillard, Stéphanie Dulucq, Anne Marie Stoppa, Didier Bouscary, François Girodon, Bernard Bonnotte, (unknown), Gèrard Socié, Thierry Lamy	35
19	Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·Mauricette Michallet, Thomas Bénet, Mohamad Sobh, (unknown), (unknown), Giovanna Cannas, Franck E. Nicolini, Hélène Labussière, Sophie Ducastelle, Fiorenza Barraco, Xavier Thomas, Youcef Chelghoum, Marie‐Christine Nicolle, Anne‐Lise Bienvenu, Florence Persat, Frédérique de Monbrison, Stéphane Picot, Philippe Vanhems	35
20	Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors 2007 ·Hélène Labussière, Sandrine Hayette, Franck E. Nicolini	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact